IFNA1 and chronic hepatitis B virus infection: In HBeAg-positive patients with chronic hepatitis B receiving polyethylene glycol IFN-α (PEG-IFNα) treatment, analysis of isolated peripheral blood mononuclear cells (PBMCs) showed significant improvement in NK cell responses, including enhanced proliferation, activation, and antiviral effects [30].